Proof of concept and mode of action of a novel modular platform for adoptive T cell therapy combining bispecific antibodies with synthetic agonistic receptors. (March 2018) - Karches, C.; Benmebarek, M.; Schmidbauer, M.; Kurzay, M.; Klaus, R.; Geiger, M.; Lesch, S.; Cadilha, B.; Rataj, F.; Heise, C.; Murr, R.; vom Berg, J.; et al.